Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State
PHASE1CompletedINTERVENTIONAL
Enrollment
200
Participants
Timeline
Start Date
July 25, 2017
Primary Completion Date
July 6, 2018
Study Completion Date
July 6, 2018
Conditions
Healthy Participants
Interventions
DRUG
AJM347
Oral administration
DRUG
Placebo
Oral administration
Trial Locations (1)
Unknown
Covance Clinical Research Unit (CRU) Ltd, Leeds
All Listed Sponsors
lead
EA Pharma Co., Ltd.
INDUSTRY
NCT03133468 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State | Biotech Hunter | Biotech Hunter